Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

计划入组 210 人 · 首次发布于 2026 年 5 月 29 日

Diffuse Fibrotic Lung Disease

首次发布于 1999 年 10 月 28 日

Pirfenidone for Progressive Fibrotic Sarcoidosis

计划入组 60 人 · 首次发布于 2017 年 8 月 24 日

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

Fibrotic Diseases(Recursion)

Anti-fibrotic agent

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Ventoux Biosciences Secures U.S. Patent for Novel Dupuytren's Disease Treatment Approach

MediciNova Advances Dual-Pipeline Strategy with Novel Therapeutics for Neurological and Metabolic Disorders

Entera Bio and OPKO Health Announce Positive PK/PD Results for Oral Oxyntomodulin for Obesity and Metabolic Disorders